中危肺栓塞:超声心动图预测临床恶化的指标
本研究为前瞻性观察性研究,纳入306例中危肺栓塞患者,旨在明确经胸超声心动图(TTE)指标对5天内临床恶化的预测价值。结果显示115例(37.6%)发生临床恶化;恶化组基线RV扩张更明显、收缩功能更差(RV基底径4.46±0.77 vs 4.20±0.77 cm,RV/LV比值1.14±0.29 vs 1.02±0.24,TAPSE 1.56±0.55 vs 1.80±0.52 cm)。多因素分析中短暂性低血压、最高心率、最高呼吸频率及RV/LV比值为独立预测因素,logistic回归和随机森林AUC分别为0.80(0.73,0.87)和0.78(0.70,0.85)。
要点
- 306例中危肺栓塞患者中115例(37.6%)在5天内发生临床恶化。
- 恶化组RV基底径4.46±0.77 cm高于无恶化组4.20±0.77 cm,RV/LV比值1.14±0.29高于1.02±0.24。
- 预测恶化的最佳阈值:RV基底径3.9 cm(OR 2.85 [1.64, 4.97]),RV/LV比值1.08(OR 3.32 [2.07, 5.33]),TAPSE 1.98 cm(OR 3.3 [2.06, 5.3])。
- 多因素独立预测因素:短暂性低血压OR 6.1(2.2, 18.9),最高心率OR 1.02(1.00, 1.03),最高呼吸频率OR 1.02(1.00, 1.04),RV/LV比值OR 1.29(1.14, 1.47)。
- logistic回归AUC 0.80(0.73, 0.87),随机森林AUC 0.78(0.70, 0.85)。
适用人群与场景
- 成人中危肺栓塞患者,前瞻性观察性研究纳入306例。
诊断标准与关键阈值
- 预测5天内临床恶化的最佳阈值:RV基底径3.9 cm(OR 2.85 [1.64, 4.97]),RV/LV比值1.08(OR 3.32 [2.07, 5.33]),TAPSE 1.98 cm(OR 3.3 [2.06, 5.3]),RV收缩期位移速度10.10 cm/s(OR 2.85 [1.75, 4.63]),利钠肽190 pg/mL(OR 2.89 [1.81, 4.62])。
研究设计与关键结果
- 前瞻性观察性研究,纳入306例中危肺栓塞患者,115例(37.6%)在5天内发生临床恶化。
- 恶化组与无恶化组比较:RV基底径4.46±0.77 vs 4.20±0.77 cm;RV/LV基底宽度比值1.14±0.29 vs 1.02±0.24;TAPSE 1.56±0.55 vs 1.80±0.52 cm;RV收缩期位移速度10.40±3.58 vs 12.1±12.5 cm/s。
- 多因素分析显示独立预测因素:短暂性低血压OR 6.1(2.2, 18.9),最高心率OR 1.02(1.00, 1.03),最高呼吸频率OR 1.02(1.00, 1.04),RV/LV比值OR 1.29(1.14, 1.47)。
- logistic回归AUC 0.80(0.73, 0.87),随机森林AUC 0.78(0.70, 0.85)。
证据类型、等级与局限
- 证据类型:前瞻性观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基线RV基底径、RV/LV比值及RV收缩功能测量在中危肺栓塞患者中可按后续是否临床恶化分组显示显著差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: We determine the predictive value of transthoracic echocardiographic (TTE) metrics for clinical deterioration within 5 days in adults with intermediate-risk pulmonary embolism (PE).
METHODS: This was a prospective observational study of intermediate-risk PE patients. To determine associations of TTE and clinical predictors with clinical deterioration, we used univariable analysis, Youden's index for optimal thresholds, and multivariable analyses to report odds ratios (ORs) or area under the curve (AUC).
RESULTS: Of 306 intermediate-risk PE patients, 115 (37.6%) experienced clinical deterioration. PE patients who had clinical deterioration within 5 days had greater baseline right ventricle (RV) dilatation and worse systolic function than the group without clinical deterioration as indicated by the following: RV basal diameter 4.46 ± 0.77 versus 4.20 ± 0.77 cm; RV/LV basal width ratio 1.14 ± 0.29 versus 1.02 ± 0.24; tricuspid annular plane systolic excursion (TAPSE) 1.56 ± 0.55 versus 1.80 ± 0.52 cm; and RV systolic excursion velocity 10.40 ± 3.58 versus 12.1 ± 12.5 cm/s, respectively. Optimal thresholds for predicting clinical deterioration were: RV basal width 3.9 cm (OR 2.85 [1.64, 4.97]), RV-to-left ventricle (RV/LV) ratio 1.08 (OR 3.32 [2.07, 5.33]), TAPSE 1.98 cm (OR 3.3 [2.06, 5.3]), systolic excursion velocity 10.10 cm/s (OR 2.85 [1.75, 4.63]), and natriuretic peptide 190 pg/mL (OR 2.89 [1.81, 4.62]). Significant independent predictors were: transient hypotension 6.1 (2.2, 18.9), highest heart rate 1.02 (1.00, 1.03), highest respiratory rate 1.02 (1.00, 1.04), and RV/LV ratio 1.29 (1.14, 1.47). By logistic regression and random forest analyses, AUCs were 0.80 (0.73, 0.87) and 0.78 (0.70, 0.85), respectively.
CONCLUSIONS: Basal RV, RV/LV ratio, and RV systolic function measurements were significantly different between intermediate-risk PE patients grouped by subsequent clinical deterioration.
参考来源
- Weekes AJ, Fraga DN, Belyshev V, et al. Intermediate-risk pulmonary embolism: echocardiography predictors of clinical deterioration. Crit Care. 2022. PMID: 35659340. doi:10.1186/s13054-022-04030-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。